Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 742976, 8 pages
http://dx.doi.org/10.1155/2012/742976
Review Article

It Is All in the Blood: The Multifaceted Contribution of Circulating Progenitor Cells in Diabetic Complications

1Department of Medicine, University of Padua, 35100 Padua, Italy
2Laboratory of Experimental Diabetology, Venetian Institute of Molecular Medicine (VIMM), 35100 Padua, Italy

Received 9 January 2012; Accepted 27 January 2012

Academic Editor: Paolo Fiorina

Copyright © 2012 Gian Paolo Fadini and Angelo Avogaro. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Avogaro, G. P. Fadini, A. Gallo, E. Pagnin, and S. De Kreutzenberg, “Endothelial dysfunction in type 2 diabetes mellitus,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 16, no. 1, supplement, pp. S39–S45, 2006. View at Publisher · View at Google Scholar
  3. A. Avogaro, S. V. D. Kreutzenberg, and G. Fadini, “Endothelial dysfunction: causes and consequences in patients with diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 82, no. 2, supplement, pp. S94–S101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Z. Ratajczak, E. K. Zuba-Surma, W. Wojakowski, J. Ratajczak, and M. Kucia, “Bone marrow—home of versatile stem cells,” Transfusion Medicine and Hemotherapy, vol. 35, no. 3, pp. 248–259, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Cesselli, A. P. Beltrami, S. Rigo et al., “Multipotent progenitor cells are present in human peripheral blood,” Circulation Research, vol. 104, no. 10, pp. 1225–1234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Asahara, T. Murohara, A. Sullivan et al., “Isolation of putative progenitor endothelial cells for angiogenesis,” Science, vol. 275, no. 5302, pp. 964–967, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Xu, H. Arai, X. Zhuge et al., “Role of bone marrow-derived progenitor cells in cuff-induced vascular injury in mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 3, pp. 477–482, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Orlic, J. Kajstura, S. Chimenti et al., “Bone marrow cells regenerate infarcted myocardium,” Nature, vol. 410, no. 6829, pp. 701–705, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. E. T. H. Yeh, S. Zhang, H. D. Wu, M. Körbling, J. T. Willerson, and Z. Estrov, “Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo,” Circulation, vol. 108, no. 17, pp. 2070–2073, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Quaini, K. Urbanek, A. P. Beltrami et al., “Chimerism of the transplanted heart,” New England Journal of Medicine, vol. 346, no. 1, pp. 5–15, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Spencer, D. Rampling, P. Aurora, D. Bonnet, S. L. Hart, and A. Jaffé, “Transbronchial biopsies provide longitudinal evidence for epithelial chimerism in children following sex mismatched lung transplantation,” Thorax, vol. 60, no. 1, pp. 60–62, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Ishikawa, M. Yasukawa, S. Yoshida et al., “Human cord blood- and bone marrow-derived CD34+ cells regenerate gastrointestinal epithelial cells,” FASEB Journal, vol. 18, no. 15, pp. 1958–1960, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. E. P. Van Poelgeest, H. J. Baelde, E. L. Lagaaij et al., “Endothelial cell chimerism occurs more often and earlier in female than in male recipients of kidney transplants,” Kidney International, vol. 68, no. 2, pp. 847–853, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. K. Hagensen, J. Shim, T. Thim, E. Falk, and J. F. Bentzon, “Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis,” Circulation, vol. 121, no. 7, pp. 898–905, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J. E. Bluff, M. W. J. Ferguson, S. O'Kane, and G. Ireland, “Bone marrow-derived endothelial progenitor cells do not contribute significantly to new vessels during incisional wound healing,” Experimental Hematology, vol. 35, no. 3, pp. 500–506, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. G. P. Fadini, I. Baesso, M. Albiero, S. Sartore, C. Agostini, and A. Avogaro, “Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau,” Atherosclerosis, vol. 197, no. 2, pp. 496–503, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Rohde, C. Bartmann, K. Schallmoser et al., “Immune cells mimic the morphology of endothelial progenitor colonies in vitro,” Stem Cells, vol. 25, no. 7, pp. 1746–1752, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Aicher, A. M. Zeiher, and S. Dimmeler, “Mobilizing endothelial progenitor cells,” Hypertension, vol. 45, no. 3, pp. 321–325, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Takahashi, C. Kalka, H. Masuda et al., “Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization,” Nature Medicine, vol. 5, no. 4, pp. 434–438, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. G. P. Fadini, S. Sartore, C. Agostini, and A. Avogaro, “Significance of endothelial progenitor cells in subjects with diabetes,” Diabetes Care, vol. 30, no. 5, pp. 1305–1313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. C. G. Egan, F. Caporali, A. F. Huqi et al., “Reduced levels of putative endothelial progenitor and CXCR4+ cells in coronary artery disease: kinetics following percutaneous coronary intervention and association with clinical characteristics,” Thrombosis and Haemostasis, vol. 101, no. 6, pp. 1138–1146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. G. P. Fadini, S. Sartore, M. Albiero et al., “Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 9, pp. 2140–2146, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. G. P. Fadini, S. Sartore, I. Baesso et al., “Endothelial progenitor cells and the diabetic paradox,” Diabetes Care, vol. 29, no. 3, pp. 714–716, 2006. View at Google Scholar · View at Scopus
  24. H. Makino, S. Okada, A. Nagumo et al., “Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy: short report,” Diabetic Medicine, vol. 26, no. 2, pp. 171–173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Albiero, L. Menegazzo, E. Boscaro, C. Agostini, A. Avogaro, and G. P. Fadini, “Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice,” Diabetologia, vol. 54, pp. 945–953, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. O. M. Tepper, R. D. Galiano, J. M. Capla et al., “Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures,” Circulation, vol. 106, no. 22, pp. 2781–2786, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. G. P. Fadini, “An underlying principle for the study of circulating progenitor cells in diabetes and its complications,” Diabetologia, vol. 51, no. 7, pp. 1091–1094, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. G. P. Fadini, S. Maruyama, T. Ozaki et al., “Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis,” PLoS ONE, vol. 5, no. 7, Article ID e11488, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. G. P. Fadini, S. de Kreutzenberg, C. Agostini et al., “Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes,” Atherosclerosis, vol. 207, no. 1, pp. 213–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Sata, A. Saiura, A. Kunisato et al., “Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis,” Nature Medicine, vol. 8, no. 4, pp. 403–409, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Saiura, M. Sata, Y. Hirata, R. Nagai, and M. Makuuchi, “Circulating smooth muscle progenitor cells contribute to atherosclerosis,” Nature Medicine, vol. 7, no. 4, pp. 382–383, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. J. F. Bentzon, C. Weile, C. S. Sondergaard, J. Hindkjaer, M. Kassem, and E. Falk, “Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in apoE knockout mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 12, pp. 2696–2702, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. K. Hagensen, J. Shim, E. Falk, and J. F. Bentzon, “Flanking recipient vasculature, not circulating progenitor cells, contributes to endothelium and smooth muscle in murine allograft vasculopathy,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 4, pp. 808–813, 2011. View at Publisher · View at Google Scholar
  34. M. Albiero, L. Menegazzo, and G. P. Fadini, “Circulating smooth muscle progenitors and atherosclerosis,” Trends in Cardiovascular Medicine, vol. 20, no. 4, pp. 133–140, 2010. View at Publisher · View at Google Scholar
  35. G. P. Fadini and M. Tjwa, “A role for TGF-beta in transforming endothelial progenitor cells into neointimal smooth muscle cells,” Atherosclerosis, vol. 211, no. 1, pp. 32–35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Zoll, V. Fontaine, P. Gourdy et al., “Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition,” Cardiovascular Research, vol. 77, no. 3, pp. 471–480, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. A. H. S. Kumar, P. Metharom, J. Schmeckpeper, S. Weiss, K. Martin, and N. M. Caplice, “Bone marrow-derived CX3CR1 progenitors contribute to neointimal smooth muscle cells via fractalkine CX3CR1 interaction,” FASEB Journal, vol. 24, no. 1, pp. 81–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Belmadani, M. Zerfaoui, H. A. Boulares, D. I. Palen, and K. Matrougui, “Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, αvβ3-integrin, and TGF-β1 in response to ANG II and high glucose,” American Journal of Physiology - Heart and Circulatory Physiology, vol. 295, no. 1, pp. H69–H76, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Q. Nguyen, H. Chon, F. A. Van Nieuwenhoven, B. Braam, M. C. Verhaar, and R. Goldschmeding, “Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6: a novel clue to adverse tissue remodelling?” Diabetologia, vol. 49, no. 5, pp. 1039–1048, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Ikarashi, B. Li, M. Suwa et al., “Bone marrow cells contribute to regeneration of damaged glomerular endothelial cells,” Kidney International, vol. 67, no. 5, pp. 1925–1933, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. P. E. Westerweel, C. T. J. van Velthoven, T. Q. Nguyen et al., “Modulation of TGF-β/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model,” Cardiovascular Diabetology, vol. 9, article 55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Katare, F. Riu, K. Mitchell et al., “Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132,” Circulation Research, vol. 109, no. 8, pp. 894–906, 2011. View at Publisher · View at Google Scholar
  43. P. Mancuso, I. Martin-Padura, A. Calleri et al., “Circulating perivascular progenitors: a target of PDGFR inhibition,” International Journal of Cancer, vol. 129, no. 6, pp. 1344–1350, 2011. View at Publisher · View at Google Scholar
  44. G. P. Fadini, P. Mancuso, F. Bertolini, S. Vigili de Kreutzenberg, and A. Avogaro, “Amelioration of glucose control mobilizes circulating pericyte progenitor cells in type 2 diabetic patients with microangiopathy,” Experimental Diabetes Research. In press.
  45. D. Orlic, J. A. N. Kajstura, S. Chimenti, D. M. Bodine, A. Leri, and P. Anversa, “Transplanted adult bone marrow cells repair myocardial infarcts in mice,” Annals of the New York Academy of Sciences, vol. 938, pp. 221–230, 2001. View at Google Scholar · View at Scopus
  46. E. Höcht-Zeisberg, H. Kahnert, K. Guan et al., “Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation,” European Heart Journal, vol. 25, no. 9, pp. 749–758, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. M. A. Laflamme, D. Myerson, J. E. Saffitz, and C. E. Murry, “Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts,” Circulation Research, vol. 90, no. 6, pp. 634–640, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. W. Wojakowski, M. Tendera, A. Michałowska et al., “Mobilization of CD34/CXCR4+, CD34/CD117+, c-met + stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction,” Circulation, vol. 110, no. 20, pp. 3213–3220, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Ausoni, T. Zaglia, A. Dedja et al., “Host-derived circulating cells do not significantly contribute to cardiac regeneration in heterotopic rat heart transplants,” Cardiovascular Research, vol. 68, no. 3, pp. 394–404, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. C. E. Murry, M. H. Soonpaa, H. Reinecke et al., “Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts,” Nature, vol. 428, no. 6983, pp. 664–668, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Badorff, R. P. Brandes, R. Popp et al., “Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes,” Circulation, vol. 107, no. 7, pp. 1024–1032, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Rupp, C. Badorff, M. Koyanagi et al., “Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells,” Basic Research in Cardiology, vol. 99, no. 1, pp. 61–68, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. W. J. Jeffcoate, L. M. Rasmussen, L. C. Hofbauer, and F. L. Game, “Medial arterial calcification in diabetes and its relationship to neuropathy,” Diabetologia, vol. 52, no. 12, pp. 2478–2488, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. G. P. Fadini, P. Pauletto, A. Avogaro, and M. Rattazzi, “The good and the bad in the link between insulin resistance and vascular calcification,” Atherosclerosis, vol. 193, no. 2, pp. 241–244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. L. C. Doehring, C. Heeger, Z. Aherrahrou et al., “Myeloid CD34+CD13+ precursor cells transdifferentiate into chondrocyte-like cells in atherosclerotic intimal calcification,” American Journal of Pathology, vol. 177, no. 1, pp. 473–480, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Y. Speer, H. Y. Yang, T. Brabb et al., “Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries,” Circulation Research, vol. 104, no. 6, pp. 733–741, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Gössl, U. I. Mödder, E. J. Atkinson, A. Lerman, and S. Khosla, “Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis,” Journal of the American College of Cardiology, vol. 52, no. 16, pp. 1314–1325, 2008. View at Publisher · View at Google Scholar
  58. M. Gössl, U. I. Mödder, R. Gulati et al., “Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells,” European Heart Journal, vol. 31, no. 23, pp. 2909–2914, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Pirro, G. Schillaci, M. R. Mannarino et al., “Circulating immature osteoprogenitor cells and arterial stiffening in postmenopausal osteoporosis,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 9, pp. 636–642, 2011. View at Publisher · View at Google Scholar
  60. G. P. Fadini, M. Albiero, L. Menegazzo et al., “Pro-calcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease,” Experimental Diabetes Research. In press.
  61. G. P. Fadini, M. Albiero, L. Menegazzo et al., “Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes,” Circulation Research, vol. 108, no. 9, pp. 1112–1121, 2011. View at Publisher · View at Google Scholar
  62. G. Z. Eghbali-Fatourechi, J. Lamsam, D. Fraser, D. Nagel, B. L. Riggs, and S. Khosla, “Circulating osteoblast-lineage cells in humans,” New England Journal of Medicine, vol. 352, no. 19, pp. 1959–1966, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Khosla, “The bone and beyond: a shift in calcium,” Nature Medicine, vol. 17, pp. 430–431, 2011. View at Google Scholar
  64. M. Pirro, C. Leli, G. Fabbriciani et al., “Association between circulating osteoprogenitor cell numbers and bone mineral density in postmenopausal osteoporosis,” Osteoporosis International, vol. 21, no. 2, pp. 297–306, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Kojima, M. Fujimiya, K. Matsumura et al., “NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice,” Nature Medicine, vol. 9, no. 5, pp. 596–603, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. H. Kojima, M. Fujimiya, K. Matsumura, T. Nakahara, M. Hara, and L. Chan, “Extrapancreatic insulin-producing cells in multiple organs in diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 8, pp. 2458–2463, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. T. Terashima, H. Kojima, and L. Chan, “Bone marrow expression of poly(ADP-ribose) polymerase underlies diabetic neuropathy via hematopoietic-neuronal cell fusion,” FASEB Journal, vol. 26, no. 1, pp. 295–308, 2012. View at Publisher · View at Google Scholar
  68. M. Fujimiya, H. Kojima, M. Ichinose et al., “Fusion of proinsulin-producing bone marrow-derived cells with hepatocytes in diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 10, pp. 4030–4035, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Terashima, H. Kojima, M. Fujimaya et al., “The fusion of bone-marrow-derived proinsulin-expressing with nerve cells underlies diabetic neuropathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 35, pp. 12525–12530, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. L. Chan, T. Terashima, H. Urabe, F. Lin, and H. Kojima, “Pathogenesis of diabetic neuropathy: bad to the bone,” Annals of the New York Academy of Sciences, vol. 1240, no. 1, pp. 70–76, 2011. View at Publisher · View at Google Scholar
  71. T. Yamashita, M. Fujimiya, K. Nagaishi et al., “Fusion of bone marrow-derived cells with renal tubules contributes to renal dysfunction in diabetic nephropathy,” FASEB Journal. In press.
  72. G. P. Fadini, S. Sartore, M. Schiavon et al., “Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats,” Diabetologia, vol. 49, no. 12, pp. 3075–3084, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. D. J. Ceradini, D. Yao, R. H. Grogan et al., “Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice,” Journal of Biological Chemistry, vol. 283, no. 16, pp. 10930–10938, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. C. F. Bento and P. Pereira, “Regulation of hypoxia-inducible factor 1 and the loss of the cellular response to hypoxia in diabetes,” Diabetologia, vol. 54, no. 8, pp. 1946–1956, 2011. View at Publisher · View at Google Scholar
  75. A. Oikawa, M. Siragusa, F. Quaini et al., “Diabetes mellitus induces bone marrow microangiopathy,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 3, pp. 498–508, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. J. V. Busik, M. Tikhonenko, A. Bhatwadekar et al., “Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock,” Journal of Experimental Medicine, vol. 206, no. 13, pp. 2897–2906, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. G. P. Fadini, E. Boscaro, S. De Kreutzenberg et al., “Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes,” Diabetes Care, vol. 33, no. 5, pp. 1097–1102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. F. Ferraro, S. Lymperi, S. Méndez-Ferrer et al., “Diabetes impairs hematopoietic stem cell mobilization by altering niche function,” Science Translational Medicine, vol. 3, no. 104, article 104ra101, 2011. View at Publisher · View at Google Scholar
  79. J. F. DiPersio, “Diabetic stem-cell "mobilopathy",” New England Journal of Medicine, vol. 365, no. 26, pp. 2536–2538, 2011. View at Publisher · View at Google Scholar
  80. G. P. Fadini, “Is bone marrow another target of diabetic complications?” European Journal of Clinical Investigation, vol. 41, no. 4, pp. 457–463, 2011. View at Publisher · View at Google Scholar
  81. S. R.K. Seshasai, S. Kaptoge, A. Thompson et al., “Diabetes mellitus, fasting glucose, and risk of cause-specific death,” New England Journal of Medicine, vol. 364, no. 9, pp. 829–841, 2011. View at Publisher · View at Google Scholar
  82. A. Petrelli, R. Di Fenza, M. Carvello et al., “Strategies to reverse Endothelial Progenitor Cell (EPCs) dysfunction in diabetes,” Experimental Diabetes Research. In press.
  83. M. Albiero, L. Menegazzo, A. Avogaro, and G. P. Fadini, “Pharmacologic targeting of endothelial progenitor cells,” Cardiovascular and Hematological Disorders, vol. 10, no. 1, pp. 16–32, 2010. View at Google Scholar · View at Scopus
  84. G. P. Fadini and A. Avogaro, “Potential manipulation of endothelial progenitor cells in diabetes and its complications,” Diabetes, Obesity and Metabolism, vol. 12, no. 7, pp. 570–583, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. G. P. Fadini, S. V. de Kreutzenberg, V. Mariano et al., “Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine,” Diabetes, Obesity and Metabolism, vol. 13, no. 8, pp. 718–725, 2011. View at Publisher · View at Google Scholar
  86. A. Petrelli, A. Maestroni, G. P. Fadini et al., “Improved function of circulating angiogenic cells is evident in type 1 diabetic islet-transplanted patients,” American Journal of Transplantation, vol. 10, no. 12, pp. 2690–2700, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. G. P. Fadini, E. Boscaro, M. Albiero et al., “The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1α,” Diabetes Care, vol. 33, no. 7, pp. 1607–1609, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Bernardi, G. M. Severini, G. Zauli, and P. Secchiero, “Cell-based therapies for diabetic complications,” Experimental Diabetes Research, vol. 2012, Article ID 872504, 10 pages, 2012. View at Publisher · View at Google Scholar
  89. M. J. Lipinski, G. G. L. Biondi-Zoccai, A. Abbate et al., “Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction. A collaborativec systematic review and meta-analysis of controlled clinical trials,” Journal of the American College of Cardiology, vol. 50, no. 18, pp. 1761–1767, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. G. P. Fadini, C. Agostini, and A. Avogaro, “Autologous stem cell therapy for peripheral arterial disease. Meta-analysis and systematic review of the literature,” Atherosclerosis, vol. 209, no. 1, pp. 10–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. N. Satoh, A. Shimatsu, A. Himeno et al., “Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone,” Diabetes Care, vol. 33, no. 1, article e7, 2010. View at Publisher · View at Google Scholar · View at Scopus